Below are the most recent publications written about "RNA, Small Interfering" by people in Profiles.
-
Chen S, Prescott LH, Mello CC, Phillips CM. Systematic identification of germ granule proteins reveals specialized roles in RNAi and small RNA inheritance. Genes Dev. 2026 Aug 26; 40(17-18):1484-1507.
-
Belgrad J, Summers A, Landles C, Greene JR, Hildebrand S, Knox E, Sapp E, Yamada N, Furgal R, Miller R, Osborne GF, Chase K, Luu E, Freedman J, Bramato B, McHugh N, Nnah I, Benoit V, O'Reilly D, Greer P, Bates GP, Vogt TF, Lee R, Howland D, DiFiglia M, Aronin N, Khvorova A. Blocking somatic repeat expansion and lowering huntingtin by RNAi synergize to attenuate Huntington's disease pathogenesis in mice. Sci Transl Med. 2026 Aug 12; 18(862):eaea3104.
-
Thompson MA, Hamrick SK, Borkar NA, Ravi P, Cicek YA, Lehot V, Goswami R, Nagaraj H, Nasim N, Rotello VM, Pabelick CM, Prakash YS. Polymeric nanoparticle-mediated siRNA delivery into primary human bronchial airway cells. Am J Physiol Cell Physiol. 2026 Sep 01; 331(3):C783-C796.
-
Hariharan VN, Summers A, Clipperton-Allen AE, Caiazzi J, Hildebrand SR, O' Reilly D, Tang Q, Kennedy Z, Echeverria D, McHugh N, Cooper D, Sousa J, Ferguson C, Fakih HH, Bogdanik L, Coenraads M, Khvorova A. Single-dose administration of therapeutic divalent siRNA targeting MECP2 prevents lethality in an MECP2 duplication mouse model. Nat Commun. 2026 Jul 21; 17(1).
-
Gentile JE, Corridon TL, Serack FE, Echeverria D, Kennedy ZC, Gallant-Behm CL, Hassler MR, Kinberger GA, Kelemen MN, Kamath NG, Lian Y, Gross KY, Miller R, DeSouza-Lenz K, Howard M, Guzman K, Chan N, Laversenne V, Curtis D, Fettes K, Lemaitre M, Jackson AL, Yamada K, Alterman JF, Coffey AA, Minikel EV, Khvorova A, Vallabh SM. Divalent siRNA for prion disease. Nucleic Acids Res. 2026 Apr 23; 54(8).
-
Blitek M, Le Coz O, Ogor V, Fakih HH, Khvorova A, Goyenvalle A. Efficient Downregulation of Flt-1 Mediated by Splice Switching ASO in Murine Endothelial Cells. Nucleic Acid Ther. 2026 Jun; 36(3):147-157.
-
Alterman JF, Gross KY, Khvorova A. The Approval of Redemplo for Familial Chylomicronemia Syndrome and the Many Flavors of GalNAc-Oligonucleotides. Nucleic Acid Ther. 2026 Jun; 36(3):129-134.
-
Trampel KA, Gross KY, O'Reilly D, Melisova A, Salman B, Green S, George SA, Khvorova A, Efimov IR, Efimova T. RNAi-mediated p38? silencing mitigates anthracycline cardiotoxicity in female mice. Am J Physiol Heart Circ Physiol. 2026 05 01; 330(5):H1522-H1539.
-
Papadopoulou AS, Alterman J, Landles C, Smith EJ, Conroy F, Phillips J, Canibano-Pico M, Nita IM, Osborne GF, Iqbal A, Aldous SG, Bondulich MK, Gomez-Paredes C, Sathasivam K, O'Reilly D, Echeverria D, Bobkov K, Greene JR, Aronin N, Khvorova A, Bates GP. Lowering the HTT1a transcript as an effective therapy for Huntington's disease in a knockin mouse model. Sci Transl Med. 2026 Mar 18; 18(841):eadw2495.
-
Zhang Y, Johansen MD, Ledger S, Shipley R, Zhao G, Moles E, Turville S, Thordarson P, Hansbro PM, Kavallaris M, Kelleher AD, Ahlenstiel CL. Comparative analysis of clinically approved lipid nanoparticles for intranasal siRNA delivery against SARS-CoV-2. Drug Deliv Transl Res. 2026 Oct; 16(10):3848-3871.